{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:16:01Z","timestamp":1788196561678,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Giant cell tumor of bone (GCTB) is a locally aggressive tumor driven by neoplastic mononuclear stromal cells. Stromal immunophenotyping may support diagnosis in giant cell-rich mimics and provide insight into tumor biology. Archival formalin-fixed, paraffin-embedded tissue samples from 31 GCTB cases diagnosed between 2015 and 2025 were studied and reviewed by consultant pathologists on-site and remotely to confirm the diagnosis and assess stromal atypia and mitoses. Immunohistochemistry for p63, cluster of differentiation 10 (CD10), and Ki-67 was performed and interpreted in stromal cells only; p63 and CD10 expression were categorized as low or high, and Ki-67 labeling index (LI) was grouped using a 10% cutoff. Available clinical variables included age, sex, anatomical site, tumor size, and recurrent-case status. Recurrent-case status was based on documentation at presentation or referral, not on prospectively confirmed recurrence. The mean age was 42.5\u2005\u00b1\u200515.4 years; 16\/31 cases (51.6%) were female. Recurrent-case status was recorded in 14\/31 cases (45.2%). High p63 and CD10 expression were observed in 20\/31 cases (64.5%) and 22\/31 cases (71.0%), respectively. In univariate analysis, CD10-high expression was associated with recurrent-case status (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.021), while p63-high expression showed a borderline association (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.057). Ki-67 LI was not associated with recurrent-case status (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.389). p63 expression correlated significantly with CD10 expression (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.003) and with higher Ki-67 LI. Stromal p63 and CD10 were commonly expressed in GCTB. CD10-high expression was associated with recurrent-case status in univariate analysis, but this exploratory finding should not be interpreted as recurrence prediction.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049262","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:02:25Z","timestamp":1781600545000},"page":"e49262","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Expression of p63, CD10, and Ki-67 in giant cell tumor of bone: A diagnostic immunohistochemical study"],"prefix":"10.1097","volume":"105","author":[{"given":"Heba M. K.","family":"Youssef","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0391-306X","authenticated-orcid":false,"given":"Abdulkarim","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"},{"name":"Department of Laboratory, Al-Baha Health Cluster, Ministry of Health, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd El Rahman M.","family":"Sharfeldeen","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Assiut University, Assiut, Egypt"},{"name":"Department of Oral Pathology, College of Dentistry, City University Ajman, Ajman, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhadi","family":"Samman","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia S.","family":"Mirdad","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Abdelwahed","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Noorwali","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Hassan","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates"},{"name":"Department of Pathology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Mahmoud Youssef","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Oral Radiology, Faculty of Dentistry, Zarqa University, Zarqa, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Rabie","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Al-Azhar University, Damietta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Samir","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Eldamery","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Prince Mishari bin Saud Hospital in Baljurashi, Al-Baha Health Cluster, Ministry of Health, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assem","family":"Amer","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Prince Mishari bin Saud Hospital in Baljurashi, Al-Baha Health Cluster, Ministry of Health, Al-Baha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf E. M.","family":"Ebaid","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, Al-Mowasem General Hospital, Jazan Health Cluster, Ministry of Health, Jazan, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"El-Mosely","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260831","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone.","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R3-20260831","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","article-title":"Giant-cell tumor of bone.","volume":"69","author":"Campanacci","year":"1987","journal-title":"J Bone Joint Surg Am"},{"key":"R4-20260831","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/17453670710014815","article-title":"Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years.","volume":"79","author":"Kivioja","year":"2008","journal-title":"Acta Orthop"},{"key":"R5-20260831","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/17453674.2012.711193","article-title":"Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.","volume":"83","author":"van der Heijden","year":"2012","journal-title":"Acta Orthop"},{"key":"R6-20260831","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/modpathol.2008.29","article-title":"Giant cell tumor of bone express p63.","volume":"21","author":"Dickson","year":"2008","journal-title":"Mod Pathol"},{"key":"R7-20260831","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1746-1596-7-130","article-title":"Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience.","volume":"7","author":"Hammas","year":"2012","journal-title":"Diagn Pathol"},{"key":"R8-20260831","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00428-014-1637-z","article-title":"A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50% of cells is stained.","volume":"465","author":"Maues De Paula","year":"2014","journal-title":"Virchows Arch"},{"key":"R9-20260831","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-9966-29-25","article-title":"Ki-67 immuno-histochemistry index in stage III giant cell tumor of the bone.","volume":"29","author":"Ismail","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"R10-20260831","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/2231-0770.184063","article-title":"CD10 and CD138 can be expressed in giant cell tumor of bone: an immunohistochemical study.","volume":"6","author":"Al-Abbadi","year":"2016","journal-title":"Avicenna J Med"},{"key":"R11-20260831","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1051\/sicotj\/2017041","article-title":"Giant cell tumor of bone revisited.","volume":"3","author":"Mavrogenis","year":"2017","journal-title":"SICOT J"},{"key":"R12-20260831","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","article-title":"Giant cell tumor of the extremity: a review of 349 cases from a single institution.","volume":"36","author":"Errani","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"R13-20260831","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12957-016-0871-z","article-title":"Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.","volume":"14","author":"Li","year":"2016","journal-title":"World J Surg Oncol"},{"key":"R14-20260831","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1148\/rg.331125089","article-title":"Giant cell tumor of bone: review, mimics, and new developments in treatment.","volume":"33","author":"Chakarun","year":"2013","journal-title":"Radiographics"},{"key":"R15-20260831","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod Pathol"},{"key":"R16-20260831","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.22000","article-title":"Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.","volume":"126","author":"Schaefer","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"R17-20260831","doi-asserted-by":"crossref","first-page":"1336310","DOI":"10.3389\/fphar.2024.1336310","article-title":"A comprehensive review of the literature on CD10: its function, clinical application, and prospects.","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"R18-20260831","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002640050381","article-title":"The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone.","volume":"23","author":"Antal","year":"1999","journal-title":"Int Orthop"},{"key":"R19-20260831","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5114\/pjp.2015.57252","article-title":"Prognostic value of p53 protein expression in giant cell tumor of bone.","volume":"66","author":"Yalcinkaya","year":"2015","journal-title":"Pol J Pathol"},{"key":"R20-20260831","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3390\/cancers15174249","article-title":"Histomorphometric analysis of 38 giant cell tumors of bone after recurrence as compared to changes following denosumab treatment.","volume":"15","author":"Arndt","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R21-20260831","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","article-title":"Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.","volume":"69","author":"Girolami","year":"2016","journal-title":"J Clin Pathol"},{"key":"R22-20260831","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0000000000000506","article-title":"Denosumab-treated giant cell tumor of bone exhibits morphologic overlap with malignant giant cell tumor of bone.","volume":"40","author":"Wojcik","year":"2016","journal-title":"Am J Surg Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:00:51Z","timestamp":1788195651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":21,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049262","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2026-03-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}